Microneedles as a delivery system for gene therapy

Frontiers in Pharmacology

Volumn 7, Issue MAY, 2016, Pages

  Chen, Wei ^a   Li, Hui ^a   Shi, De ^a   Liu, Zhenguo ^a   Yuan, Weien ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Approaches; Delivery; Gene; Micronnedles; Therapy

Indexed keywords

ADENOVIRUS VECTOR; BCG VACCINE; CARBOXYMETHYLCELLULOSE; CHITOSAN; CYCLODEXTRIN; INFLUENZA VACCINE; LENTIVIRUS VECTOR; NANOPARTICLE; OLIGONUCLEOTIDE; PARVOVIRUS VECTOR; PLASMID DNA; POLYETHYLENEIMINE; POLYGLACTIN; POLYLYSINE; RETROVIRUS VECTOR; SMALL INTERFERING RNA; VACCINE;

DISSOLVING MICRONEEDLE; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE GUN; HOLLOW MICRONEEDLE; HUMAN; HYDROGEL MICRONEEDLE; MICRONEEDLE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; SHORT SURVEY; SKIN CANCER; SKIN DISEASE; SKIN PENETRATION; SOLID MICRONEEDLE; STRATUM CORNEUM; ULTRASOUND; VIRAL GENE DELIVERY SYSTEM; WOUND;

EID: 84974623803     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2016.00137     Document Type: Short Survey

References (57)

1. Birchall, J., Coulman, S., Pearton, M., Allender, C., Brain, K., Anstey, A., et al. (2005). Cutaneous DNA delivery and gene expression in ex vivo human skin explants via wet-etch micro-fabricated micro-needles. J. Drug Target. 13, 415-421. doi: 10.1080/10611860500383705
2. Blaese, R. M., Culver, K. W., Miller, A. D., Carter, C. S., Fleisher, T., Clerici, M., et al. (1995). T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 270, 475-480. doi: 10.1126/science.270.5235.475
3. Bryant, L. M., Christopher, D. M., Giles, A. R., Hinderer, C., Rodriguez, J. L., Smith, J. B., et al. (2013). Lessons learned from the clinical development and market authorization of Glybera. Hum. Gene Ther. Clin. Dev. 24, 55-64. doi: 10.1089/humc.2013.087
4. Castanotto, D., and Rossi, J. J. (2009). The promises and pitfalls of RNA-interference-based therapeutics. Nature 457, 426-433. doi: 10.1038/nature07758
5. Cavalli, R., Bisazza, A., and Lembo, D. (2013). Micro-and nanobubbles: a versatile non-viral platform for gene delivery. Int. J. Pharm. 456, 437-445. doi: 10.1016/j.ijpharm.2013.08.041
6. Cavazzana-Calvo, M., Hacein-Bey, S., de Saint Basile, G., Gross, F., Yvon, E., Nusbaum, P., et al. (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288, 669-672. doi: 10.1126/science.288.5466.669
7. Chong, R. H. E., Gonzalez-Gonzalez, E., Lara, M. F., Speaker, T. J., Contag, C. H., Kaspar, R. L., et al. (2013). Gene silencing following siRNA delivery to skin via coated steel microneedles: in vitro and in vivo proof-of-concept. J. Control. Release 166, 211-219. doi: 10.1016/j.jconrel.2012.12.030
8. Cots, D., Bosch, A., and Chillón, M. (2013). Helper dependent adenovirus vectors: progress and future prospects. Curr. Gene Ther. 13, 370-381. doi: 10.2174/156652321305131212125338
9. Coulman, S., Allender, C., and Birchall, J. (2006). Microneedles and other physical methods for overcoming the stratum corneum barrier for cutaneous gene therapy. Crit. Rev. Ther. Drug Carrier Syst. 23, 205-258. doi: 10.1615/CritRevTherDrugCarrierSyst.v23.i3.20
10. Coulman, S. A., Birchall, J. C., Alex, A., Pearton, M., Hofer, B., O'Mahony, C., et al. (2011). In vivo, in situ imaging of microneedle insertion into the skin of human volunteers using optical coherence tomography. Pharm. Res. 28, 66-81. doi: 10.1007/s11095-010-0167-x
11. Donnelly, R. F. (2011). "Microneedle-mediated intradermal delivery, " in Microneedle-mediated Transdermal and Intradermal Drug Delivery, eds R. F. Donnelly, T. R. R. Singh, D. I. J. Morrow, and A. D. Woolfson (Chichester: Blackwell), 16.
12. Donnelly, R. F., Raj Singh, T. R., and Woolfson, A. D. (2010). Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv. 17, 187-207. doi: 10.3109/10717541003667798
13. Favaro, M. T. P., de Toledo, M. A. S., Alves, R. F., Santos, C. A., Beloti, L. L., Janissen, R., et al. (2014). Development of a non-viral gene delivery vector based on the dynein light chain Rp3 and the TAT peptide. J. Biotechnol. 173, 10-18. doi: 10.1016/j.jbiotec.2014.01.001
14. Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., and Mello, C. C. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811. doi: 10.1038/35888
15. Fire, A. Z. (2007). Gene silencing by double-stranded RNA (Nobel Lecture). Angew Chem Int. Ed. Engl. 46, 6966-6984. doi: 10.1002/anie.200701979
16. Frazier, S. C. B. (2003). Characterization of surface micromachined metallic microneedles. Microelectromech. Syst. 12, 289-295. doi: 10.1109/JMEMS.2003.811731
17. Gonzalez-Gonzalez, E., Ra, H., Hickerson, R. P., Wang, Q., Piyawattanametha, W., Mandella, M. J., et al. (2009). siRNA silencing of keratinocyte-specific GFP expression in a transgenic mouse skin model. Gene Ther. 16, 963-972. doi: 10.1038/gt.2009.62
18. Gonzalez-Gonzalez, E., Speaker, T. J., Hickerson, R. P., Spitler, R., Flores, M. A., Leake, D., et al. (2010). Silencing of reporter gene expression in skin using siRNAs and expression of plasmid DNA delivered by a soluble protrusion array device (PAD). Mol. Ther. 18, 1667-1674. doi: 10.1038/mt.2010.126
19. Guo, J., Evans, J. C., and O'Driscoll, C. M. (2013). Delivering RNAi therapeutics with non-viral technology: a promising strategy for prostate cancer? Trends Mol. Med. 19, 250-261. doi: 10.1016/j.molmed.2013.02.002
20. Haq, M. I., Smith, E., John, D. N., Kalavala, M., Edwards, C., Anstey, A., et al. (2009). Clinical administration of microneedles: skin puncture, pain and sensation. Biomed. Microdevices 11, 35-47. doi: 10.1007/s10544-008-9208-1
21. Hsu, T., and Mitragotri, S. (2011). Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer. Proc. Natl. Acad. Sci. U.S.A. 108, 15816-15821. doi: 10.1073/pnas.1016152108
22. Ito, Y., Hagiwara, E., Saeki, A., Sugioka, N., and Takada, K. (2006). Feasibility of microneedles for percutaneous absorption of insulin. Eur. J. Pharm. Sci. 29, 82-88. doi: 10.1016/j.ejps.2006.05.011
23. Jiang, J., Moore, J. S., Edelhauser, H. F., and Prausnitz, M. R. (2009). Intrascleral drug delivery to the eye using hollow microneedles. Pharm. Res. 26, 395-403. doi: 10.1007/s11095-008-9756-3
24. Kay, M. A., Manno, C. S., Ragni, M. V., Larson, P. J., Couto, L. B., McClelland, A., et al. (2000). Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat. Genet. 24, 257-261. doi: 10.1038/73464
25. Khuri, F. R., Nemunaitis, J., Ganly, I., Arseneau, J., Tannock, I. F., Romel, L., et al. (2000). A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat. Med. 6, 879-885. doi: 10.1038/78638
26. Kim, M., Jung, B., and Park, J. H. (2012b). Hydrogel swelling as a trigger to release biodegradable polymer microneedles in skin. Biomaterials 33, 668-678. doi: 10.1016/j.biomaterials.2011.09.074
27. Kim, Y. C., Park, J. H., and Prausnitz, M. R. (2012a). Microneedles for drug and vaccine delivery. Adv. Drug Deliv. Rev. 64, 1547-1568. doi: 10.1016/j.addr.2012.04.005
28. Koirala, A., Conley, S. M., and Naash, M. I. (2013). A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium. Biomaterials 34, 7158-7167. doi: 10.1016/j.biomaterials.2013.06.002
29. Kotterman, M. A., Chalberg, T. W., and Schaffer, D. V. (2015). Viral vectors for gene therapy: translational and clinical outlook. Annu. Rev. Biomed. Eng. 17, 63-89. doi: 10.1146/annurev-bioeng-071813-104938
30. Kumar, A., Wonganan, P., Sandoval, M. A., Li, X., Zhu, S., and Cui, Z. (2012). Microneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticles. J. Control. Release 163, 230-239. doi: 10.1016/j.jconrel.2012.08.011
31. Lai, W. F. (2014). Cyclodextrins in non-viral gene delivery. Biomaterials 35, 401-411. doi: 10.1016/j.biomaterials.2013.09.061
32. Lara, M. F., González-González, E., Speaker, T. J., Hickerson, R. P., Leake, D., Milstone, L. M., et al. (2012). Inhibition of CD44 gene expression in human skin models, using self-delivery short interfering RNA administered by dissolvable microneedle arrays. Hum. Gene Ther. 23, 816-823. doi: 10.1089/hum.2011.211
33. Lee, K., Kim, J. D., Lee, C. Y., Her, S., and Jung, H. (2011). A high-capacity, hybrid electro-microneedle for in-situ cutaneous gene transfer. Biomaterials 32, 7705-7710. doi: 10.1016/j.biomaterials.2011.06.058
34. Lentz, T. B., Gray, S. J., and Samulski, R. J. (2012). Viral vectors for gene delivery to the central nervous system. Neurobiol. Dis. 48, 179-188. doi: 10.1016/j.nbd.2011.09.014
35. Lin, L. W., and Pisano, A. P. (1999). Silicon-processed microneedles. J. Microelectromech. Syst. 8, 78-84. doi: 10.1109/84.749406
36. Liu, S., Jin, M.-N., Quan, Y.-S., Kamiyama, F., Kusamori, K., Katsumi, H., et al. (2014). Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin. Eur. J. Pharm. Biopharm. 86, 267-276. doi: 10.1016/j.ejpb.2013.10.001
37. McCaffrey, J., Donnelly, R. F., and McCarthy, H. O. (2015). Microneedles: an innovative platform for gene delivery. Drug Deliv. Trans. Res. 5, 424-437. doi: 10.1007/s13346-015-0243-1
38. McCaffrey, J., McCrudden, C. M., Ali, A. A., Massey, A. S., McBride, J. W., McCrudden, M. T., et al. (2016). Transcending epithelial and intracellular biological barriers; a prototype DNA delivery device. J. Control. Release 226, 238-247. doi: 10.1016/j.jconrel.2016.02.023
39. McLean, W. H. I., and Moore, C. B. T. (2011). Keratin disorders: from gene to therapy. Hum. Mol. Genet. 20, R189-R197. doi: 10.1093/hmg/dldr379
40. Moon, S. J., and Lee, S. S. (2005). A novel fabrication method of a microneedle array using inclined deep x-ray exposure. J. Micromech. Microeng. 15, 903-911. doi: 10.1088/0960-1317/15/5/002
41. Mountain, A. (2000). Gene therapy: the first decade. Trends Biotechnol. 18, 119-128. doi: 10.1016/S0167-7799(99)01416-X
42. Mulligan, R. C. (1993). The basic science of gene therapy. Science 260, 926-932. doi: 10.1126/science.8493530
43. Newman, C. M., Lawrie, A., Brisken, A. F., and Cumberland, D. C. (2001). Ultrasound gene therapy: on the road from concept to reality. Echocardiography 18, 339-347. doi: 10.1046/j.1540-8175.2001.00339.x
44. Niidome, T., and Huang, L. (2002). Gene therapy progress and prospects: nonviral vectors. Gene Ther. 9, 1647-1652. doi: 10.1038/sj.gt.3301923
45. Noori-Zadeh, A., Mesbah-Namin, S. A., Tiraihi, T., Rajabibazl, M., and Taheri, T. (2014). Non-viral human proGDNF gene delivery to rat bone marrow stromal cells under ex vivo conditions. J. Neurol. Sci. 339, 81-86. doi: 10.1016/j.jns.2014.01.025
46. Novobrantseva, T. I., Akinc, A., Borodovsky, A., and de Fougerolles, A. (2008). Delivering silence: advancements in developing siRNA therapeutics. Curr. Opin. Drug Discov. Dev. 11, 217-224.
47. Ovsianikov, A., Chichkov, B., Mente, P., Monteiro-Riviere, N. A., Doraiswamy, A., and Narayan, R. J. (2007). Two photon polymerization of polymer-ceramic hybrid materials for transdermal drug delivery. Int. J. Appl. Ceram. Technol. 4, 22-29. doi: 10.1111/j.1744-7402.2007.02115.x
48. Pack, D. W., Hoffman, A. S., Pun, S., and Stayton, P. S. (2005). Design and development of polymers for gene delivery. Nat. Rev. Drug Discov. 4, 581-593. doi: 10.1038/nrd1775
49. Pearton, M., Saller, V., Coulman, S. A., Gateley, C., Anstey, A. V., Zarnitsyn, V., et al. (2012). Microneedle delivery of plasmid DNA to living human skin: Formulation coating, skin insertion and gene expression. J. Control. Release 160, 561-569. doi: 10.1016/j.jconrel.2012.04.005
50. Somiari, S., Glasspool-Malone, J., Drabick, J. J., Gilbert, R. A., Heller, R., Jaroszeski, M. J., et al. (2000). Theory and in vivo application of electroporative gene delivery. Mol. Ther. 2, 178-187. doi: 10.1006/mthe.2000.0124
51. Trichur, R., Kim, S., Zhu, X., Suk, J. W., Hong, C.-C., Choi, J.-W., et al. (2002). "Development of plastic microneedles for transdermal interfacing using injection molding techniques, " in Micro Total Analysis Systems, Vol. 1, eds Y. Baba, S. Shoji, and A. van den Berg (Dordrecht: Springer Netherlands), 395-397.
52. van der Maaden, K., Jiskoot, W., and Bouwstra, J. (2012). Microneedle technologies for (trans)dermal drug and vaccine delivery. J. Control. Release 161, 645-655. doi: 10.1016/j.jconrel.2012.01.042
53. Watanabe, N., Yano, K., Tsuyuki, K., Okano, T., and Yamato, M. (2015). Re-examination of regulatory opinions in Europe: possible contribution for the approval of the first gene therapy product Glybera. Mol. Ther. Methods Clin. Dev. 2:14066. doi: 10.1038/mtm.2014.66
54. Weinberg, M., Samulski, R. J., and McCown, T. J. (2013). Adeno-associated virus (AAV) gene therapy for neurological disease. Neuropharmacology 69, 82-88. doi: 10.1016/j.neuropharm.2012.03.004
55. Whitehead, K. A., Langer, R., and Anderson, D. G. (2009). Knocking down barriers: advances in siRNA delivery. Nat. Rev. Drug Discov. 8, 129-138. doi: 10.1038/nrd2742
56. Xun, M.-M., Liu, Y.-H., Guo, Q., Zhang, J., Zhang, Q.-F., Wu, W.-X., et al. (2014). Low molecular weight PEI-appended polyesters as non-viral gene delivery vectors. Eur. J. Med. Chem. 78, 118-125. doi: 10.1016/j.ejmech.2014.03.050
57. Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., and Anderson, D. G. (2014). Non-viral vectors for gene-based therapy. Nat. Rev. Genet. 15, 541-555. doi: 10.1038/nrg3763